Jansen Olivia, Tchinda Alembert T, Loua Jean, Esters Virginie, Cieckiewicz Ewa, Ledoux Allison, Toukam Paul D, Angenot Luc, Tits Monique, Balde Aliou M, Frédérich Michel
Laboratory of Pharmacognosy, Center for Interdisciplinary Research on Medicines (CIRM), University of Liège, CHU B36, 4000 Liège, Belgium.
Center for Studies on Medicinal Plants and Traditional Medicine, Institute of Medical Research and Medicinal Plants Studies (IMPM), P.O. Box 6163 Yaoundé, Cameroon.
J Ethnopharmacol. 2017 May 5;203:20-26. doi: 10.1016/j.jep.2017.03.021. Epub 2017 Mar 18.
Decoctions of the leaves of M. benthamianum Baill. are used by traditional healers in Guinea to treat malaria and this use was validated by a preliminary clinical assay.
To evaluate the in vitro antiplasmodial activity and to identify active compounds from extracts of M. benthamianum leaves.
Antiplasmodial activity of extracts, fractions and pure compounds was evaluated in vitro against a chloroquine-sensitive strain of Plasmodium falciparum (3D7) using the measurement of the plasmodial lactate dehydrogenase activity. Selectivity of extracts and purified compounds for Plasmodium parasites was evaluated by using WST-1 test on HeLa human cells. Compounds were isolated using normal phase silica gel column chromatography and prepHPLC and their structures elucidated using extensive spectroscopic analysis.
Hydroethanolic extracts (70% v/v) of M. benthamianum leaves showed a moderate in vitro activity against P. falciparum 3D7, with IC in the range 22.5 - 32.6µg/mL, depending on the batch; while a dark precipitate formed during ethanol evaporation showed higher activity (IC =6.5µg/mL). The fractionation was performed on this most active fraction and was followed by in vitro antiplasmodial assay. Active compounds (5, 7, 8) belong to several phytochemical classes, contributing together to the global antiplasmodial activity of the hydroethanolic extract against P. falciparum parasite. This study finally allowed the isolation of three diterpenes including two new compounds named Mezobenthamic acids A (1) and B (2) and neocaesalpin H (3), as well as quercetin (4), kaempferol (7), resveratrol (6), gallic acid (9) and its ethylester (5), β-sitosterol glucoside (10) and 13b-hydroxy-pheophorbide a (8).
This study gives some concrete evidence to support the ethnopharmacological use of Mezoneuron benthamianum leaves extract in the management of malaria. The active compounds can be further studied for their antiplasmodial potential, as well as their suitability to be used as quality markers for the standardization of this herbal drug from the Guinean traditional pharmacopeia.
几内亚的传统治疗师使用本氏梅佐木(Mezoneuron benthamianum Baill.)叶的煎剂来治疗疟疾,这一用途已通过初步临床测定得到验证。
评估本氏梅佐木叶提取物的体外抗疟活性并鉴定其中的活性成分。
使用疟原虫乳酸脱氢酶活性测定法,在体外评估提取物、馏分和纯化合物对氯喹敏感的恶性疟原虫(3D7)株的抗疟活性。通过在HeLa人细胞上进行WST-1试验,评估提取物和纯化化合物对疟原虫的选择性。使用正相硅胶柱色谱法和制备型高效液相色谱法分离化合物,并通过广泛的光谱分析阐明其结构。
本氏梅佐木叶的水乙醇提取物(70% v/v)对恶性疟原虫3D7显示出中等程度的体外活性,IC50在22.5 - 32.6μg/mL范围内,具体取决于批次;而在乙醇蒸发过程中形成的深色沉淀显示出更高的活性(IC50 = 6.5μg/mL)。对该活性最高的馏分进行分馏,随后进行体外抗疟试验。活性化合物(5、7、8)属于几个植物化学类别,共同促成了水乙醇提取物对恶性疟原虫的整体抗疟活性。本研究最终分离出三种二萜类化合物,包括两种新化合物,分别命名为mezobenthamic酸A(1)和B(2)以及新刺桐素H(3),还有槲皮素(4)、山奈酚(7)、白藜芦醇(6)、没食子酸(9)及其乙酯(5)、β-谷甾醇葡萄糖苷(10)和13b-羟基脱镁叶绿酸a(8)。
本研究提供了一些具体证据,支持在疟疾治疗中使用本氏梅佐木叶提取物的民族药理学用途。活性化合物的抗疟潜力以及作为几内亚传统药典中这种草药标准化质量标志物的适用性可进一步研究。